Drugs / Anahil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05349929 | May → Nov 2022 | pulpitis | Qazvin University Of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anahil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05349929 ↗ |
| Known as | Bromelain | “Anahil ( generic name of Bromelain in Iran)” NCT05349929 ↗ |